Skip to content
Welcome
  • Welcome to NJ Vaccine Science
  • Recent Blog Post
  • About NJ Vaccine Science

NJ Vaccine Science

A site dedicated to making the case for vaccine exemptions using CDC statements, vaccine inserts, and peer reviewed science.

  • Vaccine Safety
    • Adverse Events After Vaccination – How Often They Occur
    • Adverse Effects of Vaccines Evidence and Causality – 2012 IOM Report
    • Immunity for Vaccine Manufactures & HHS Failure to Submit Safety Reports
    • Plotkin Deposition
    • WHO Global Vaccine Safety Summit
    • ACIP Meeting for Hepislav-B
    • DTP: The Story of an Unsafe Vaccine
  • Cost-Benefit Analysis
    • Hep B
    • Pertussis
    • Influenza
    • NJ Assembly Woman Vandervalk – Protecting an at-risk population
  • Herd Immunity
    • Problems with Herd Immunity: District 11 Stories
      • The Medically Complicated: Keanu
      • Vaccine Injury: Gio
      • The Medically Complicated: Michael
    • Measles & Herd Immunity
  • COVID
    • The Overwhelming Evidence for Keeping Schools Open
    • How to tell the magnitude of NJ’s second wave?
    • FLU SHOT MANDATE: WILL IT HELP DURING COVID-19?
    • Alan Dershowitz and Paul Offit Advocate for Vaccine Choice
    • CDC, Oxford, Stanford Agree, COVID-19 IFR is under 0.3%

Antibody Testing Proving Fauci right about low CFR for COVID

Dr. Facui wrote in The New England Journal of Medicine “…the case fatality rate may be considerably less than 1%. This suggests that the overall clinical consequences of Covid-19 may ultimately be more akin to those of a severe seasonal influenza ” The result of antibody testing around the world is proving him right.

Covid-19 — Navigating the Uncharted | NEJM

Stanford Study (Under Peer Review): “These prevalence estimates represent a range between 48,000 and 81,000 people infected in Santa Clara County by early April, 50-85-fold more than the number of confirmed cases.” (Estimated CFR: 0.12 – 0.2%)
COVID-19 Antibody Seroprevalence in Santa Clara County, California | medRxiv

CodonCode Corporation (Under Peer Review): “The results indicate that confirmed case numbers understate the actual number of infections substantially; during rapid growth phases where the daily growth rate can reach or exceed 30%, as has been seen in many countries, the confirmed case numbers under-report actual infections by up to 50 to 100-fold.”
https://www.medrxiv.org/content/10.1101/2020.04.13.20064220v1.full.pdf

USC Study: “Adjusting this estimate for the statistical margin of error implies about 2.8% to 5.6% of the county’s adult population has an antibody to the virus — which translates to approximately 221,000 to 442,000 adults in the county who have been infected. That estimate is 28 to 55 times higher than the 7,994 confirmed cases of COVID-19 reported to the county at the time of the study in early April. The number of COVID-related deaths in the county has now surpassed 600.” (Estimated CFR: 0.2%)
Antibody testing results: COVID-19 infections exceed confirmed cases

German Cluster Study: Around 15 percent had been infected , allowing them to calculate a COVID-19 infection fatality rate of about 0.37 percent. The researchers also concluded that people who recover from the infection are immune to reinfection, at least for a while.
For comparison, the U.S. infection fatality rates for the 1957–58 flu epidemic was around 0.27 percent; for the 1918 Spanish flu epidemic, it was about 2.6 percent . (Estimated CFR: 0.37%)
Preliminary German Study Shows a COVID-19 Infection Fatality Rate of About 0.4 Percent – Reason.com

NY Antibody Study: “More than 21 percent of around 1,300 people in New York City who were tested for coronavirus antibodies this week were found to have them , Gov. Andrew M. Cuomo said on Thursday. It would also mean that the fatality rate from the virus was relatively low, about 0.5 percent, Mr. Cuomo said.” (Estimated CFR: 0.5%)
Cuomo Says 21% of Those Tested in N.Y.C. Had Virus Antibodies – The New York Times

The Lancet, Hubei China (prior to antibody testing): “Our estimated overall infection fatality ratio for China was 0·66% (0·39–1·33), with an increasing profile with age.” (Estimated CFR: 0.66%)
Estimates of the severity of coronavirus disease 2019: a model-based analysis – The Lancet Infectious Diseases

Boston Homeless Shelter: “A total of 147 participants (36.0%) had PCR test results positive for SARS-CoV-2. Men constituted 84.4% of individuals with PCR-positive results and 64.4% of individuals with PCR-negative results. Among individuals with PCR test results positive for SARS-CoV-2, cough (7.5%), shortness of breath (1.4%), and fever (0.7%) were all uncommon, and 87.8% were asymptomatic.”
Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston | Infectious Diseases | JAMA | JAMA Network

Take Action:

1. Sign up for NJ Vaccine Science action alerts via email.

2. Stay Informed – check our our Blog and Advocacy Home page for action items, follow us on Twitter, and like us on Facebook.

3. Call and Email your Senator and Assemblymembers – ask them to oppose bill S902/A969. Use this link to find your representatives’ phone number and send them a message.

4. Call and Email the Bill Sponsors: Senate President Sweeney: [email protected] / 856-251-9801; Assemblyman Conway  [email protected] / (856) 461-3997

If you live in Legislative District 11 sign our D11 Petition to protect NJ’s RE. 

Contact NJ Vaccine Science at:

[email protected]

Sign Up for Email Action Alerts

Email Address *

First Name *

Last Name *

* indicates required


Other Useful Websites:

Hope from Holly

Vaccine Papers

National Vaccine Information Center

Informed Consent Action Network

Vaccine Injury and Compensation Program

DISCLAIMER:

All information, data and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advise. The decision to vaccinate and how you implement that decision is yours and yours alone. You are encouraged to consult with your medical professional and legal adviser.

© 2025 NJ Vaccine Science

Proudly powered by WordPress | Theme: Xblog Plus by wpthemespace.com